Trial of Indole-3-Carbinol & Silibinin
Trial of Indole-3-Carbinol & Silibinin
This is a non-therapeutic, Phase 1 clinical trial to examine the safety, pharmacokinetic (PK) characteristics, and pharmacodynamics (PD) effect of indole-3-carbinol (I3C) and silibinin (Sil) in healthy subjects.
Inclusion Criteria:
Adult ≥ 18 years old
Current smoker of ≥ 8 cigarettes per day for at least the last 6 months by self-report
Adequate blood counts, and adequate liver and kidney function defined as follows:
Able to understand the experimental nature of the study and provide informed written consent
Exclusion Criteria: